212 related articles for article (PubMed ID: 26880857)
1. Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder Cancer.
Kim HS; Ku JH
Dis Markers; 2016; 2016():8345286. PubMed ID: 26880857
[TBL] [Abstract][Full Text] [Related]
2. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
3. The prognostic values of tumor-infiltrating neutrophils, lymphocytes and neutrophil/lymphocyte rates in bladder urothelial cancer.
Liu K; Zhao K; Wang L; Sun E
Pathol Res Pract; 2018 Aug; 214(8):1074-1080. PubMed ID: 29803657
[TBL] [Abstract][Full Text] [Related]
4. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer.
Cantiello F; Russo GI; Vartolomei MD; Farhan ARA; Terracciano D; Musi G; Lucarelli G; Di Stasi SM; Hurle R; Serretta V; Busetto GM; Scafuro C; Perdonà S; Borghesi M; Schiavina R; Cioffi A; De Berardinis E; Almeida GL; Bove P; Lima E; Ucciero G; Matei DV; Crisan N; Verze P; Battaglia M; Guazzoni G; Autorino R; Morgia G; Damiano R; de Cobelli O; Mirone V; Shariat SF; Ferro M
Eur Urol Oncol; 2018 Oct; 1(5):403-410. PubMed ID: 31158079
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review.
Marchioni M; Primiceri G; Ingrosso M; Filograna R; Castellan P; De Francesco P; Schips L
Clin Genitourin Cancer; 2016 Dec; 14(6):473-484. PubMed ID: 27209348
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study.
Favilla V; Castelli T; Urzì D; Reale G; Privitera S; Salici A; Russo GI; Cimino S; Morgia G
Int Braz J Urol; 2016; 42(4):685-93. PubMed ID: 27564278
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
Lee SM; Russell A; Hellawell G
Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
9. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS
Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.
Kawahara T; Furuya K; Nakamura M; Sakamaki K; Osaka K; Ito H; Ito Y; Izumi K; Ohtake S; Miyoshi Y; Makiyama K; Nakaigawa N; Yamanaka T; Miyamoto H; Yao M; Uemura H
BMC Cancer; 2016 Mar; 16():185. PubMed ID: 26944862
[TBL] [Abstract][Full Text] [Related]
12. Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
Dalpiaz O; Ehrlich GC; Mannweiler S; Hernández JM; Gerger A; Stojakovic T; Pummer K; Zigeuner R; Pichler M; Hutterer GC
BJU Int; 2014 Sep; 114(3):334-9. PubMed ID: 24053693
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory biomarkers and bladder cancer prognosis: a systematic review.
Masson-Lecomte A; Rava M; Real FX; Hartmann A; Allory Y; Malats N
Eur Urol; 2014 Dec; 66(6):1078-91. PubMed ID: 25151017
[TBL] [Abstract][Full Text] [Related]
14. The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease.
Paquissi FC
Ther Clin Risk Manag; 2016; 12():851-60. PubMed ID: 27313459
[TBL] [Abstract][Full Text] [Related]
15. Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?
Cimen HI; Halis F; Saglam HS; Gokce A
Int Braz J Urol; 2017; 43(1):67-72. PubMed ID: 28124528
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
Mano R; Baniel J; Shoshany O; Margel D; Bar-On T; Nativ O; Rubinstein J; Halachmi S
Urol Oncol; 2015 Feb; 33(2):67.e1-7. PubMed ID: 25060672
[TBL] [Abstract][Full Text] [Related]
17. Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome.
Luo HL; Chen YT; Chuang YC; Cheng YT; Lee WC; Kang CH; Chiang PH
BJU Int; 2014 May; 113(5b):E144-9. PubMed ID: 24274691
[TBL] [Abstract][Full Text] [Related]
18. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma.
Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Schlinke A; Alber G; Rösch S; Steiner JM; Seeger J; Oechtering GU; Heilmann RM
BMC Vet Res; 2022 Nov; 18(1):412. PubMed ID: 36411489
[TBL] [Abstract][Full Text] [Related]
19. Importance of the neutrophil-to-lymphocyte ratio in muscle-invasive and non-muscle invasive bladder tumors.
Ceylan C; Doluoglu OG; Keleş I; Gazel E; Temuçin T; Odabaş Ö; Karalar M
Urologia; 2014; 81(2):120-4. PubMed ID: 24474540
[TBL] [Abstract][Full Text] [Related]
20. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J
J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
